We’re currently experiencing extremely high call volumes. We’re very sorry for any inconvenience this might cause.

If you need help with your account, please visit our Help Centre, or email us and we’ll get back to you as soon as we can. For more information and tips on managing your account online please visit www.hl.co.uk/coronavirus

We’re experiencing high call volumes, please check FAQs before calling.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

DarioHealth Corp (DRIO) USD0.0001

Sell:$6.35 Buy:$10.00 Change: $0.37 (5.62%)
NASDAQ:0.95%
Market closed |  Prices as at close on 31 March 2020 | Switch to live prices |
Sell:$6.35
Buy:$10.00
Change: $0.37 (5.62%)
Market closed |  Prices as at close on 31 March 2020 | Switch to live prices |
Sell:$6.35
Buy:$10.00
Change: $0.37 (5.62%)
Market closed |  Prices as at close on 31 March 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company's product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter. The Dario product is a digital diabetes management solution utilizing its technology delivered through a software application available for iPhone or Android and cloud-based data services with a blood glucose monitoring system device. Dario allows users to record, analyze, transmit and store various data points, such as glucose level, insulin and carbohydrate intake. It markets the Dario Smart Diabetes Management Solution in the Netherlands and New Zealand.

Contact details

Address:
8 Hatokhen St.
CAESAREA
38900
Israel
Telephone:
+972 (3) 6222929
Website:
mydario.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
DRIO
ISIN:
US23725P2092
Market cap:
$20.31 million
Shares in issue:
3.10 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Yoav Shaked
    Chairman of the Board
  • Richard Anderson
    President, General Manager - North America
  • Erez Raphael
    Chief Executive Officer, Director
  • Zvi Ben-David
    Chief Financial Officer, Treasurer, Secretary
  • Dror Bacher
    Chief Operating Officer
  • Olivier Jarry
    Senior Vice President - Strategy and Business Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.